fluoroquinolones

Preferred Label : fluoroquinolones;

MeSH definition : A group of QUINOLONES with at least one fluorine atom and a piperazinyl group.; A group of 4-QUINOLONES with at least one fluorine atom typically at the C-6 and a piperazinyl or other nitrogen-containing heterocyclic group at the C-7 position of the quinoline ring.;

MeSH synonym : Fluoroquinolone;

Wikipedia automatic translation : Quinolone;

Wikipedia link : https://en.wikipedia.org/wiki/Quinolone;

Is substance : O;

Details

Origin ID

D024841;

UMLS CUI

C0949665;

ATC code(s)
- fluoroquinolones [ATC Code]
ATC code(s)
- fluoroquinolones [ATC Code]
- fluoroquinolones [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Fluoroquinolone [LOINC component]
- Fluoroquinolone (substance) [SNOMED CT concept]
- Fluoroquinolone Antibiotic [NCIt concept]
Pharmacological action(s)
- anti-bacterial agents [MeSH Descriptor]
- nucleic acid synthesis inhibitors [MeSH Descriptor]
Record concept(s)
- fluoroquinolones [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,2-dihydro-9,1-(epoxymethano)-7-fluoro-8-(4-methyl-1-piperazinyl)-5-oxo-5H-thiazolo(3,2-a)quinoline-4-carboxylic acid [MeSH Supplementary Concept]
- 1-((1R, 2S)-2-fluorocyclopropyl)fluoroquinolone [MeSH Supplementary Concept]
- 1-(5-amino-2,4-difluorophenyl)-6-fluoro-8-methyl-7-methylamino-4-oxo-1,4-dihydroquinoline-3-carboxylic acid [MeSH Supplementary Concept]
- 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxyic acid [MeSH Supplementary Concept]
- 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid [MeSH Supplementary Concept]
- 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-((4-p-nitrobenzol)-1-piperazinyl)quinoline-3-carboxylic acid [MeSH Supplementary Concept]
- 4-((2-cyclobutyl-1H-imidazo(4,5-b)pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one [MeSH Supplementary Concept]
- 6-difluoromethoxy-7-piperazinyl-3-quinolonecarboxylic acid [MeSH Supplementary Concept]
- 6-fluoro-1-cyclopropyl-1,4-dihydro-4-oxo-7-(pyrrol-1-yl)quinoline-3-carboxylic acid [MeSH Supplementary Concept]
- 7(3-amino-2-methyl-1-azetidinyl)-1-(2,4- difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-3-quinolinecarboxylic acid tosylate [MeSH Supplementary Concept]
- 7-(3-(2-amino-1-fluoroethylidene)-1-piperidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid [MeSH Supplementary Concept]
- 7-(3-aminopyrrolo(3,4-c)pyrazol-5(2H,4H,6H)-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid [MeSH Supplementary Concept]
- 7-(4'-amino-2'-methylpyrrolidinyl)-1-(2,4-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid [MeSH Supplementary Concept]
- 7-(7-amino-7-methyl-5-azaspiro(2.4)heptan-5-yl)-6-fluoro-1-(2-fluoro-1-cyclopropyl)-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid [MeSH Supplementary Concept]
- 7-(8'-methyl-3',8'-diazabicyclo(3.2.1)oct-3'-yl)-1-cyclopropyl-6- fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid [MeSH Supplementary Concept]
- 7-amino-1-(5-amino-2,4-difluorophenyl)-6-fluoro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid [MeSH Supplementary Concept]
- 7-chloro-6-fluoro-1-ethyl-1,4-dihydro-4-oxopyrido(2,3-c)pyridazine-3-carboxylic acid [MeSH Supplementary Concept]
- 9-(4-aminopiperazin-1-yl)-8-fluoro-3-methyl-6-oxo-2,3-dihydro-6H-1-oxa-3a-azaphenalene-5-carboxylic acid [MeSH Supplementary Concept]
- A 65281 [MeSH Supplementary Concept]
- A 65282 [MeSH Supplementary Concept]
- A 71497 [MeSH Supplementary Concept]
- A 80556 [MeSH Supplementary Concept]
- AF 3013 [MeSH Supplementary Concept]
- AM-1121 [MeSH Supplementary Concept]
- BMY 40062 [MeSH Supplementary Concept]
- BMY 45243 [MeSH Supplementary Concept]
- BO 2367 [MeSH Supplementary Concept]
- CFC 222 [MeSH Supplementary Concept]
- CI 934 [MeSH Supplementary Concept]
- CP 115953 [MeSH Supplementary Concept]
- CP 115955 [MeSH Supplementary Concept]
- CP 67015 [MeSH Supplementary Concept]
- CP 67804 [MeSH Supplementary Concept]
- CPUY013 compound [MeSH Supplementary Concept]
- CQ-M-EPCA [MeSH Supplementary Concept]
- CS 940 [MeSH Supplementary Concept]
- DK-507k [MeSH Supplementary Concept]
- DS-8587 [MeSH Supplementary Concept]
- DV 7751a [MeSH Supplementary Concept]
- DW-116 [MeSH Supplementary Concept]
- E 3604 [MeSH Supplementary Concept]
- E 4441 [MeSH Supplementary Concept]
- E 4497 [MeSH Supplementary Concept]
- E 4695 [MeSH Supplementary Concept]
- E-4868 [MeSH Supplementary Concept]
- FA-103 [MeSH Supplementary Concept]
- K-12, fluoroquinolone [MeSH Supplementary Concept]
- MBX-500 [MeSH Supplementary Concept]
- MF 961 [MeSH Supplementary Concept]
- N-(3-chlorophenyl)-N-((8-fluoro-2-oxo-1,2-dihydroquinolin-4-yl)methyl)-4-methylthiazole-5-carboxamide [MeSH Supplementary Concept]
- N-desmethylrufloxacin [MeSH Supplementary Concept]
- NSFQ-104 [MeSH Supplementary Concept]
- NSFQ-105 [MeSH Supplementary Concept]
- P-floxacin [MeSH Supplementary Concept]
- PD 117588 [MeSH Supplementary Concept]
- PD 124816 [MeSH Supplementary Concept]
- PD 131628 [MeSH Supplementary Concept]
- PD 138312 [MeSH Supplementary Concept]
- PD 140248 [MeSH Supplementary Concept]
- PD-117596 [MeSH Supplementary Concept]
- S 34109 [MeSH Supplementary Concept]
- T 3762 [MeSH Supplementary Concept]
- WCK 1152 [MeSH Supplementary Concept]
- WCK 1153 [MeSH Supplementary Concept]
- WCK 771 [MeSH Supplementary Concept]
- WQ 3034 [MeSH Supplementary Concept]
- WQ-3810 [MeSH Supplementary Concept]
- Y 688 [MeSH Supplementary Concept]
- Y904 [MeSH Supplementary Concept]
- alatrofloxacin [MeSH Supplementary Concept]
- balofloxacin [MeSH Supplementary Concept]
- bay Y3118 [MeSH Supplementary Concept]
- benofloxacin [MeSH Supplementary Concept]
- besifloxacin [MeSH Supplementary Concept]
- borocin [MeSH Supplementary Concept]
- cadrofloxacin [MeSH Supplementary Concept]
- chinfloxacin [MeSH Supplementary Concept]
- cifran [MeSH Supplementary Concept]
- clinafloxacin [MeSH Supplementary Concept]
- danofloxacin [MeSH Supplementary Concept]
- delafloxacin [MeSH Supplementary Concept]
- enrofloxacin-trimethoprim combination [MeSH Supplementary Concept]
- finafloxacin [MeSH Supplementary Concept]
- flumequine [MeSH Supplementary Concept]
- fluoroquinoline K-37 [MeSH Supplementary Concept]
- fluoroquinolone-pyrrolo(2,1-c)(1,4)benzodiazepine [MeSH Supplementary Concept]
- garenoxacin [MeSH Supplementary Concept]
- grepafloxacin [MeSH Supplementary Concept]
- lascufloxacin [MeSH Supplementary Concept]
- levonadifloxacin [MeSH Supplementary Concept]
- lomefloxacin [MeSH Supplementary Concept]
- marbofloxacin [MeSH Supplementary Concept]
- nadifloxacin [MeSH Supplementary Concept]
- nefloxacin [MeSH Supplementary Concept]
- olamufloxacin [MeSH Supplementary Concept]
- pazufloxacin [MeSH Supplementary Concept]
- perfloxacin [MeSH Supplementary Concept]
- pradofloxacin [MeSH Supplementary Concept]
- premafloxacin [MeSH Supplementary Concept]
- prulifloxacin [MeSH Supplementary Concept]
- rufloxacin [MeSH Supplementary Concept]
- sinafloxacin [MeSH Supplementary Concept]
- sitafloxacin [MeSH Supplementary Concept]
- sparfloxacin [MeSH Supplementary Concept]
- temafloxacin [MeSH Supplementary Concept]
- tetracyclic quinolone no. 5290 [MeSH Supplementary Concept]
- tosufloxacin [MeSH Supplementary Concept]
- trovafloxacin [MeSH Supplementary Concept]
- ulifloxacin [MeSH Supplementary Concept]
- win 57273 [MeSH Supplementary Concept]
- zabofloxacin [MeSH Supplementary Concept]
See also (suggested by CISMeF)
- photosensitization [MeSH concept]
- tendinitis [MeSH concept]
See also inter- (CISMeF)
- Drug-induced photosensitivity (disorder) [SNOMED CT concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Fluoroquinolone [LOINC component]
- Fluoroquinolone (substance) [SNOMED CT concept]
- Fluoroquinolone Antibiotic [NCIt concept]
Validated automatic mappings to BTNT
- fluoroquinolones [ATC Code]
- fluoroquinolones [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients